A single institution clinical trial to verify the utility of aroma Lymphatic tressage for edema of lower extremities associated with the taxane chemotherapy in patients with breast cancer

Not Applicable

Recruiting

• Conditions: Neoplasms

• Registration Number: KCT0005951
• Lead Sponsor: Korea University Anam Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 March 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

1. Patients with breast cancer who are indicated for taxane treatmentn (regardless of adjuvant or palliative purpose)
(AC followed by Docetaxel/Paclitaxel, AC followed by Docetaxel/Paclitaxel + Trastuzumab, TAC, TC, TCHP, Docetaxel/Paclitaxel monotherapy, Paclitaxel+Cisplatin, Paclitaxel+Carboplatin, Docetaxel+Epirubicin, Paclitaxel+Ifosfamide)
2. Patients within 6 weeks after completion of treatment with taxane anticancer drugs (Docetaxel, paclitaxel)
3. Patients with lower extremity edema of CTCAE v5.0 Generalized edema grade 2 or higher after taxane administration
4. Over 20 years old
5. A person who agrees to the subject explanation and consent form
6. A person who can fill out a questionnaire in Korean according to the standards.
7. A person who is willing to comply with the research plan and adhere to the treatment plan during the research period.

Exclusion Criteria

1. Patients with known side effects of Taxane-based anticancer drugs.
2. Patients with soft tissue infection at the massage site
3. Patients with extensive bone metastases
4. Patients with severe musculoskeletal disorders or peripheral vascular disease, as judged by the researcher
5. Those who are currently receiving massage care.
6. History of major surgery or severe trauma within 28 days of study start.
7. Substance abusers who are judged to interfere with research participation and interpretation of research results
Those with medical/psychiatric/social diseases.
8. According to the researcher's judgment, a patient who has a medical condition that may increase the risk due to participation in the study or interfere with the interpretation of the study results, or who have abnormal laboratory test values.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified